Brighton Jones’s Aldeyra Therapeutics ALDX Stock Holding History
Bought
Maintained
Sold
Other funds holding ALDX
6CM
Brighton Jones's ALDX Position: Q3 2026 in Review
Brighton Jones sold out of Aldeyra Therapeutics (ALDX) in Q3 2026, closing a stake of 16,144 shares — an estimated $34.4K sold.
Brighton Jones first reported a position in ALDX in Q2 2025 and held it in 4 quarters. The position peaked at $104K in Q3 2025. 71 funds tracked by Wall St. Rank hold ALDX as of Q3 2026.
- Brighton Jones reported no remaining Aldeyra Therapeutics position as of Q3 2026 after selling out during the quarter.
- Brighton Jones sold 16,144 Aldeyra Therapeutics shares in Q3 2026, an estimated $34.4K.
- Brighton Jones first reported a position in Aldeyra Therapeutics in Q2 2025 and held it in 4 quarters.
- Brighton Jones's Aldeyra Therapeutics position peaked at $104K in Q3 2025.
- 71 funds tracked by Wall St. Rank held Aldeyra Therapeutics as of Q3 2026.
Based on Brighton Jones's 13F filing for Q3 2026, filed 3 Nov 2026.